Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 306

The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.

Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition

Kato, Mototsugu, Ota, Hiroyoshi, Okuda, Masumi, Kikuchi, Shogo, Satoh, Kiichi, Shimoyama, Tadashi, Suzuki, Hidekazu, Handa, Osamu, Furuta, Takahisa, Mabe, Katsuhiro, Murakami, Kazunari, Sugiyama, Toshiro, Uemura, Naomi, Takahashi, Shin'ichi·2019·Helicobacter

Abstract

Background: Since “Helicobacter pylori (H. pylori) infection” was set as the indication in the Japanese Society for Helicobacter Research (JSHR) Guidelines 2009, eradication treatment for H. pylori gastritis is covered under insurance since 2013 in Japan, and the number of H. pylori eradication has rapidly increased. Under such circumstances, JSHR has made the third revision to the “Guidelines for diagnosis and treatment of H. pylori infection” for the first time in 7 years. Methods: The Guideline Committee held 10 meetings. Articles published between the establishment of the 2009 Guidelines and March 2016 were reviewed and classified according to the evidence level; the statements were revised on the basis of this review. After inviting public comments, the revised statements were finalized using the Delphi method. Results: There was no change in the basic policy that H. pylori infectious disease is an indication for eradication. Other diseases presumed to be associated with H. pylori infection were added as indications. Serum pepsinogen level, endoscopic examination, and X‐ray examination were added to the diagnostic methods. The effects of 1‐week triple therapy consisting of potassium‐competitive acid blocker (P‐CAB), amoxicillin, and clarithromycin have improved, and high eradication rates can also be expected with proton pump inhibitors (PPI) or P‐CAB combined with amoxicillin and metronidazole. If the susceptibility test is not performed, the triple PPI or P‐CAB/amoxicillin/metronidazole therapy should be chosen, because the PPI/amoxicillin/metronidazole combination demonstrated a significantly higher eradication rate than PPI/amoxicillin/clarithromycin. In the proposal for gastric cancer prevention, we divided gastric cancer prevention measures by age from adolescent to elderly, who are at an increased gastric cancer risk, and presented measures for gastric cancer prevention primarily based on H. pylori eradication. Conclusion: We expect the revised guidelines to facilitate appropriate interventions for patients with H. pylori infection and accomplish its eradication and prevention of gastric cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/hel.12597

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 97 references

Cited by

See all 306

Metadata

Authors
Kato, M., Ota, H., Okuda, M., Kikuchi, S., Satoh, K., Shimoyama, T., Suzuki, H., Handa, O., Furuta, T., Mabe, K., Murakami, K., Sugiyama, T., Uemura, N., & Takahashi, S.
Venue
Helicobacter
Publisher
Wiley
Published
2019-05-20
Volume
24
Issue
4
Pages
e12597-e12597
ISSN
  • 1083-4389 (ISSN-L)
  • 1523-5378
OpenAlex
W2945155413
Cited by
306
References
97
FWCI
27.01
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition. https://app.cochat.ai/papers/10.1111/hel.12597
The paper
Kato, M., Ota, H., Okuda, M., Kikuchi, S., Satoh, K., Shimoyama, T., Suzuki, H., Handa, O., Furuta, T., Mabe, K., Murakami, K., Sugiyama, T., Uemura, N., & Takahashi, S. (2019). Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition. Helicobacter. https://doi.org/10.1111/hel.12597

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.